Equity Capital Markets

Company · CIK 1714798

Prevail Therapeutics Inc.

CIK1714798 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Incorporated inDE
Business addressNY
Listedno ticker on SEC record today
First annual or quarterly report2019-08-14

Offerings

2 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-239612
ShelfEffective
 2020-07-012021-01-264
333-231754
IPOFinal prospectus
 2019-05-242019-06-204

Filings

9
FiledFilingRegistrationAccession
2021-01-26EFFECTDeclared effective 333-2396129999999995-21-000278
2020-08-11424B5Shelf takedown 333-2396120001193125-20-215724
2020-07-08EFFECTDeclared effective 333-2396129999999995-20-001719
2020-07-01S-3Shelf registered 333-2396120001193125-20-185248
2019-06-20424B4Final prospectus 333-2317540001193125-19-177602
2019-06-19EFFECTDeclared effective 333-2317549999999995-19-001379
2019-06-10S-1/AAmendment 333-2317540001193125-19-168749
2019-05-24S-1Registration filed 333-2317540001193125-19-157078
2019-03-27DRSDraft made public 377-025600000950123-19-002856

All filings of this company · CSV